4//SEC Filing
O'Neill Gilmore Neil 4
Accession 0001650664-25-000037
CIK 0001650664other
Filed
Mar 26, 8:00 PM ET
Accepted
Mar 27, 4:37 PM ET
Size
7.5 KB
Accession
0001650664-25-000037
Insider Transaction Report
Form 4
O'Neill Gilmore Neil
DirectorCEO
Transactions
- Award
Stock Option (right to buy)
2025-03-08+828,000→ 828,000 totalExercise: $1.72Exp: 2035-03-07→ Common Stock (828,000 underlying) - Award
Stock Option (right to buy)
2025-03-08+175,000→ 175,000 totalExercise: $1.72Exp: 2035-03-07→ Common Stock (175,000 underlying)
Footnotes (2)
- [F1]This option was granted on March 8, 2025 and is scheduled to vest over four years in equal monthly installments beginning on April 8, 2025 through March 8, 2029.
- [F2]This option was granted on March 8, 2025 and is scheduled to vest in full on September 8, 2026.
Documents
Issuer
Editas Medicine, Inc.
CIK 0001650664
Entity typeother
Related Parties
1- filerCIK 0001742084
Filing Metadata
- Form type
- 4
- Filed
- Mar 26, 8:00 PM ET
- Accepted
- Mar 27, 4:37 PM ET
- Size
- 7.5 KB